1. 33 Developing a transgenic mouse model with inducible cardiac fibroblast-selective deletion of the interleukin-1 receptor, IL1R1. (17th November 2015) Authors: Hemmings, KE; Bageghni, SA; Pinteaux, E; Drinkhill, MJ; Turner, NA Journal: Heart Issue: Volume 101(2015)Supplement 6 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A TRANSGENIC APPROACH TO STUDY THE EFFECT OF CARDIAC FIBROBLAST-SPECIFIC ABLATION OF IL-1 SIGNALLING ON MYOCARDIAL REMODELLING. (21st November 2014) Authors: Hemmings, KE; Bageghni, SA; Porter, KE; Drinkhill, MJ; Ainscough, JFX; Turner, NA Journal: Heart Issue: Volume 100:(2014)Supplement 4 Page Start: A19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. T4 Cardiac fibroblast P38α map kinase is essential for cardiomyocyte hypertrophy and cardiac dysfunction following myocardial injury. (26th October 2016) Authors: Bageghni, SA; Hemmings, KE; Porter, KE; Ainscough, JFX; Drinkhill, MJ; Turner, NA Journal: Heart Issue: Volume 102(2016)Supplement 8 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗